COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,905 Articles (22,568 medRxiv, 8,337 bioRxiv)

Most recent first Previous |  Page 400: Articles 3991-4000  | Next

Surveillance of Vermont wildlife in 2021-2022 reveals no detected SARS-CoV-2 viral RNA
Despres, H. W., Mills, M. G., Schmidt, M. M., Gov, J., Perez, Y., Jindrich, M., Crawford, A. M. L., Kohl, W. T., Rosenblatt, E., Kubinski, H. C., Simmons, B. C., Nippes, M. C., Goldenberg, A. J., Murtha, K. E., Nicoloro, S., Harris, M. J., Feeley, A. C., Gelinas, T. K., Cronin, M. K., Frederick, R. S., Thomas, M., Johnson, M. E., Murphy, J., Lenzini, E. B., Carr, P. A., Berger, D. H., Mehta, S. P., Floreani, C. J., Koval, A. C., Young, A. L., Fish, J. H., Wallace, J., Chaney, E., Ushay, G., Waterman, M., Ross, R. S., Vostal, E. M., Thisner, M. C., Gonet, K. E., Deane, O. C., Kari, P. R., Rockafeller, V. C., Waterman, M., Barry, T. W., Goering, C. C., Shipman, S. D., Shiers, A. C., Reilly, C. E., Duff, A. M., Shirley, D. J., Jerome, K. R., Perez-Osorio, A. C., Greninger, A. L., Fortin, N., Mosher, B. A., Bruce, E. A.
10.1101/2023.04.25.538264 — Posted: 2023-04-26
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Damron, F. H., Lee, K. S., Rader, N. A., Miller-Stump, O. A., Cooper, M., Wong, T. Y., Amin, M. S., Barbier, M., Bevere, J. R., Ernst, R. K.
10.1101/2023.04.25.538294 — Posted: 2023-04-26
Human SARS-CoV-2 challenge resolves local and systemic response dynamics
Lindeboom, R. G. H., Worlock, K. B., Dratva, L. M., Yoshida, M., Scobie, D., Wagstaffe, H. R., Richardson, L., Wilbrey-Clark, A. L., Barnes, J. L., Polanski, K., Allen-Hyttinen, J., Mehta, P., Sumanaweera, D., Boccacino, J. M., Sungnak, W., Huang, N., Mamanova, L., Kapuge, R., Bolt, L., Prigmore, E., Killingley, B., Kalinova, M., Mayer, M., Boyers, A., Mann, A., Teixeira, V. H., Janes, S. M., Chambers, R. C., Haniffa, M., Catchpole, A., Heyderman, R. S., Noursadeghi, M., Chain, B., Mayer, A., Meyer, K. B., Chiu, C., Nikolic, M. Z., Teichmann, S. A.
10.1101/2023.04.13.23288227 — Posted: 2023-04-25
Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: a multicentre UK-based study
Sorrell, L., Leta, V., Barnett, A., Stevens, K., King, A., Inches, J., Kobylecki, C., Walker, R., Chaudhuri, K. R., Martin, H., Rideout, J., Sneyd, J. R., Campbell, S., Carroll, C., The COVID-19 PD UK Study Team
10.1101/2023.04.24.23289022 — Posted: 2023-04-25
Covid-19 Vaccine Booster Cadence by Immunocompromised Status
Yechezkel, M., Faust, J., Netzer, D., Razi-Benita, T., Shmueli, E., Arbel, R., Yamin, D.
10.1101/2023.04.18.23288615 — Posted: 2023-04-25
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
Gravenstein, S., Devone, F., Oyebanji, O., Abul, Y., Cao, Y., Chan, P., Halladay, C., McConeghy, K., Nugent, C., Bosch, J., King, C., Wilson, B., Balazs, A. B., White, E., Canaday, D. H.
10.1101/2023.04.25.23289050 — Posted: 2023-04-25
Time series analysis of daily data of COVID-19 reported cases in Japan from January 2020 to February 2023
Sumi, A.
10.1101/2023.04.19.23288796 — Posted: 2023-04-25
Risks of digestive diseases in long COVID: Evidence from a large-scale cohort study
Ma, Y., Zhang, L., Wei, R., Dai, W., Zeng, R., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F. W., Duan, C., Sha, W., Chen, H.
10.1101/2023.04.25.23289080 — Posted: 2023-04-25
Using extracted data from Kaplan-Meier curves to compare COVID-19 vaccine efficacy
Tansawet, A.
10.1101/2023.04.19.23288799 — Posted: 2023-04-25
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Springer, D. N., Bauer, M., Medits, I., Camp, J. V., Aberle, S. W., Burtscher, C., Hoeltl, E., Weseslindtner, L., Stiasny, K., Aberle, J. H.
10.1101/2023.04.20.23288813 — Posted: 2023-04-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).